Food News and Research

RSS

Research looks at health and environmental effects of exposure to nanoparticles

A new study raises the possibility that flies and other insects that encounter nanomaterial "hot spots," or spills, near manufacturing facilities in the future could pick up and transport nanoparticles on their bodies, transferring the particles to other flies or habitats in the environment.

6 Aug 2009

Aradigm receives orphan drug designation for inhaled liposomal ciprofloxacin to treat cystic fibrosis in Europe

Aradigm Corporation (OTCBB:ARDM) has announced that the European Medicines Agency (EMEA) granted Orphan Drug Designation to the Company’s inhaled liposomal ciprofloxacin drug product candidate for the treatment of lung infections associated with cystic fibrosis (“CF”).

6 Aug 2009

In Kenya, Clinton calls on African leaders to promote good governance, women's rights

U.S. Secretary of State Hillary Clinton on Wednesday in Kenya "re-affirmed the new U.S. administration's commitment towards expanding its partnership with African countries, expressing optimism in the continent's long-term potential for growth and development," VOA News reports.

5 Aug 2009

Indian Government asks UNICEF to stop distribution of nutrition aid

"The increasingly heated fight over health-care legislation is saturating the summer airwaves, with groups on all sides of the debate pouring tens of millions of dollars into advertising campaigns designed to push the cause of reform forward, slow it down or stop it in its tracks," the Washington Post reports.

5 Aug 2009

Healthy choices to prevent cancer

In today's troubled economy, saving money is a hot topic. No matter what gets cut from your budget, however, experts at The University of Texas M. D. Anderson Cancer Center believe that healthy choices to prevent cancer shouldn't be on the list.

5 Aug 2009

Sensitizing tumor response to cancer treatment

Two forms of skin and brain cancer respond very poorly to chemotherapy and radiation: melanoma and glioblastoma multiforme brain cancer.

5 Aug 2009

Food selection depends on whom you dine with

If you are a woman who dines with a man, chances are you choose food with fewer calories than if you dine with a woman. That is one of the findings in a study conducted by researchers at McMaster University.

5 Aug 2009

Leptin influences baseline dopamine levels and motivation to eat

As we all know from experience, people eat not only because they are hungry, but also because the food just simply tastes too good to pass up. Now, a new study in the August 6th Cell Metabolism, a Cell Press publication, helps to explain how leptin, a hormone produced by fat tissue, influences that motivation to eat.

5 Aug 2009

Health care reform must avoid conflicts-of-interest

As President Obama and Congress weigh changes in the nation’s health care system they must avoid creating a system where physicians are financially motivated to pressure patients into mandated treatments that conflict with their values and needs, two Beth Israel Deaconess Medical Center physicians warn.

5 Aug 2009

Impax Labs receives FDA approval for generic version of Depakote

Impax Laboratories has confirmed that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New Drug Application (ANDA) for generic version of Depakote® (divalproex ER) 500mg Extended-release Tablets.

5 Aug 2009

Iowa funds swine vaccine research

A grant from a state economic development fund will help Iowa State University researchers develop and evaluate a vaccine designed to protect swine from novel H1N1 and other strains of influenza.

5 Aug 2009

3D science-based film opens at the Health Museum

Imagine exploring an alien world where odd creatures roam bizarre terrain in search of food. Then witness the attack and counterattack of viral bacteria at a cellular level. Now imagine it all in 3D!

5 Aug 2009

Epicept files NDA for Ceplene in Canada

EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.

5 Aug 2009

Cancer Therapy & Research Center (CTRC) retains status as NCI-designated cancer center

The National Cancer Institute, the nation’s top cancer research organization, has renewed the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio as one of its NCI-designated Cancer Centers for three years. The distinction comes with $5.4 million in new federal funding through 2012 to sustain and grow the cancer center’s rapidly expanding research programs, now consisting of 140 scientists at work on a multitude of cancer projects.

4 Aug 2009

Clinton heads to Kenya as Africa visit begins

Secretary of State Hillary Rodham Clinton kicked off a seven country, 11-day trip — "her longest overseas journey to date as the top U.S. diplomat — by flying Monday night to Kenya where she will address an African trade and development forum, meet top Kenyan officials and see the beleaguered president of lawless Somalia's interim government," the Associated Press reports.

4 Aug 2009

International conference on food science and technology

...

4 Aug 2009

Boosting agricultural research in the developing world key to food security

Boosting agricultural research in the developing world is the key to ensuring food security for the world's poorest, says Adel el-Beltagy, Chair of the Global Form on Agricultural Research (GFAR), writing in the latest issue of the TWAS Newsletter, published last week.

4 Aug 2009

Dietary supplements with steroids pose health risks

Three cases of patients suffering from the adverse affects of steroid-enriched dietary supplements have been reported by researchers at Henry Ford Hospital.

4 Aug 2009

Accelerating the development of new cancer drugs

A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months. Investigators from The University of Texas M. D. Anderson Cancer Center and pharmaceutical company AstraZeneca have reported their work in the Journal of Clinical Oncology published online on August 3rd.

4 Aug 2009

Antidepressant use becoming more common in the United States

A marked and broad expansion in antidepressant treatment occurred among Americans older than 6 years between 1996 and 2005, although treatment rates remain low among racial and ethnic minorities, according to a report in the August issue of Archives of General Psychiatry.

4 Aug 2009